Iqvia price target raised to $240 from $210 at HSBC
HSBC analyst Sidharth Sahoo raised the firm's price target on Iqvia to $240 from $210 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space o